AC
RYTM icon

Athanor Capital’s Rhythm Pharmaceuticals RYTM Stock Holding History

Athanor Capital’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,631
Closed -$524K – 1012
2020
Q4 		$524K Buy
17,631
+5,211
+42% +$132K 0.01% 459
2020
Q3 		$269K Sell
12,420
-13,929
-53% -$319K 0.01% 448
2020
Q2 		$588K Buy
+26,349
New +$514K 0.03% 277
2020
Q1 		– Sell
-24,871
Closed -$571K – 312
2019
Q4 		$571K Buy
+24,871
New +$553K 0.03% 231

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Athanor Capital's RYTM Position: Q1 2021 in Review

Athanor Capital sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2021, closing a stake of 17,631 shares — an estimated $524K sold.

Athanor Capital first reported a position in RYTM in Q4 2019 and held it in 4 quarters. The position peaked at $588K in Q2 2020. 124 funds tracked by Wall St. Rank hold RYTM as of Q1 2021.

  • Athanor Capital reported no remaining Rhythm Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 17,631 Rhythm Pharmaceuticals shares in Q1 2021, an estimated $524K.
  • Athanor Capital first reported a position in Rhythm Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Athanor Capital's Rhythm Pharmaceuticals position peaked at $588K in Q2 2020.
  • 124 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.